Kenneth Bernstein, MD

Director, Experimental Pathology

Kenneth E. Bernstein, MD is the Director of the Experimental Pathology Division in the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center. He also is Professor of Pathology at Cedars-Sinai.

Dr. Bernstein is a world-renowned experimental and renal pathologist who has authored in excess of 125 peer review articles. His research focus is on angiotensin converting enzyme and its receptors, and he has made seminal discoveries in this field of study. Dr. Bernstein has been recognized for his significant contributions, as evidenced by his receipt of the American Heart Association (AHA) Basic Research Prize, the AHA Novartis Award in Hypertension Research, and a National Institutes of Health (NIH) MERIT Award, among other honors. He currently holds two active NIH grants and participates in a third. He is on the editorial board of three high impact journals, and is a reviewer for more than 30 additional journals. Dr. Bernstein also is a frequent grant reviewer, having sat on NIH study sections many times.

Board certified in anatomic pathology, Dr. Bernstein is committed to medical education as evidenced by his participation in renal pathology medical student courses. He is a sought-after mentor for undergraduate and graduate students, and postdoctoral fellows, having advised more than 30 trainees. Dr. Bernstein also is actively involved in the graduate program at Cedars-Sinai, serving as faculty advisor to several PhD students in the Experimental Pathology Division.

Dr. Bernstein received his medical degree from New York University School of Medicine followed by a residency in Pathology at Columbia-Presbyterian Hospital in New York and the National Cancer Institute and National Institutes of Health, Bethesda, MD. This was followed by two additional years at the NIH as Special Assistant to the Director in the Institute of Diabetes, Digestive and Kidney Diseases.